Abstract
A method is described for the simultaneous determination of amodiaquine (AQ) and desethylamodiaquine (AQm) in plasma, urine, whole blood and packed red cells. After oral administration of AQ (600 mg) to seven healthy subjects, absorption of AQ was rapid, reaching peak concentrations in plasma, whole blood, and packed cells at 0.5 +/- 0.03, 0.5 +/- 0.1 and 0.5 +/- 0.1 h respectively (mean +/- s.e. mean). The apparent terminal half-life of AQ was 5.2 +/- 1.7 h. AQ was detectable for no longer than 8 h. AQ underwent rapid conversion to AQm, which reached peak concentrations in plasma, whole blood and packed cells at 3.4 +/- 0.8, 2.3 +/- 0.5 and 3.6 +/- 1.1 h respectively. AQm was still detectable at the end of the sampling period (96 h) when the plasma concentration was 29 +/- 8 ng ml-1. The area under the plasma concentration vs time curve (AUC(0, infinity] for AQ was 154 +/- 38 ng ml-1 h; the corresponding value for AQm was 8037 +/- 1383 ng ml-1 h. There were no significant differences in the values for AUC of AQ between plasma, whole blood, or packed cells. The whole blood to plasma concentration ratio for AQm was 3.1 +/- 0.2, and the AUC (0.24) for AQm in whole blood (6811 +/- 752 ng ml-1 h) was significantly greater than that in plasma (2304 +/- 371 ng ml-1 h), P less than 0.001. The recovery of AQm from urine collected 0-24 h was 6.8 +/- 0.8 mg (n = 6).(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergqvist Y., Domeij-Nyberg B. Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr. 1983 Jan 14;272(1):137–148. doi: 10.1016/s0378-4347(00)86110-1. [DOI] [PubMed] [Google Scholar]
- Booth K., Larkin K., Maddocks I. Agranulocytosis coincident with amodiaquine therapy. Br Med J. 1967 Jul 1;3(5556):32–33. doi: 10.1136/bmj.3.5556.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Churchill F. C., Mount D. L., Patchen L. C., Björkman A. Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods. J Chromatogr. 1986 Apr 25;377:307–318. doi: 10.1016/s0378-4347(00)80786-0. [DOI] [PubMed] [Google Scholar]
- Churchill F. C., Patchen L. C., Campbell C. C., Schwartz I. K., Nguyen-Dinh P., Dickinson C. M. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci. 1985 Jan 7;36(1):53–62. doi: 10.1016/0024-3205(85)90285-1. [DOI] [PubMed] [Google Scholar]
- GLICK L. Fatal agranulocytosis during treatment with a amodiaquine. Br Med J. 1957 Apr 20;1(5024):932–932. doi: 10.1136/bmj.1.5024.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gustafsson L. L., Walker O., Alván G., Beermann B., Estevez F., Gleisner L., Lindström B., Sjöqvist F. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol. 1983 Apr;15(4):471–479. doi: 10.1111/j.1365-2125.1983.tb01532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hatton C. S., Peto T. E., Bunch C., Pasvol G., Russell S. J., Singer C. R., Edwards G., Winstanley P. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet. 1986 Feb 22;1(8478):411–414. doi: 10.1016/s0140-6736(86)92371-8. [DOI] [PubMed] [Google Scholar]
- Lind D. E., Levi J. A., Vincent P. C. Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro. Br Med J. 1973 Feb 24;1(5851):458–460. doi: 10.1136/bmj.1.5851.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Looareesuwan S., Phillips R. E., White N. J., Karbwang J., Benjasurat Y., Attanath P., Warrell D. A. Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria. Lancet. 1985 Oct 12;2(8459):805–808. doi: 10.1016/s0140-6736(85)90796-2. [DOI] [PubMed] [Google Scholar]
- Mihaly G. W., Nicholl D. D., Edwards G., Ward S. A., Orme M. L., Warrell D. A., Breckenridge A. M. High-performance liquid chromatographic analysis of amodiaquine in human plasma. J Chromatogr. 1985 Jan 11;337(1):166–171. doi: 10.1016/0378-4347(85)80025-6. [DOI] [PubMed] [Google Scholar]
- Neftel K. A., Woodtly W., Schmid M., Frick P. G., Fehr J. Amodiaquine induced agranulocytosis and liver damage. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):721–723. doi: 10.1136/bmj.292.6522.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pussard E., Verdier F., Blayo M. C., Pocidalo J. J. Biotransformation de l'amodiaquine et prophylaxie du paludisme à Plasmodium falciparum. C R Acad Sci III. 1985;301(8):383–385. [PubMed] [Google Scholar]
- Salako L. A., Idowu O. R. Failure to detect amodiaquine in the blood after oral administration. Br J Clin Pharmacol. 1985 Oct;20(4):307–311. doi: 10.1111/j.1365-2125.1985.tb05068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watkins W. M., Sixsmith D. G., Spencer H. C., Boriga D. A., Kariuki D. M., Kipingor T., Koech D. K. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet. 1984 Feb 18;1(8373):357–359. doi: 10.1016/s0140-6736(84)90410-0. [DOI] [PubMed] [Google Scholar]
- Winstanley P. A., Edwards G., Orme M. L., Breckenridge A. M. The detection of amodiaquine in blood after oral administration. Br J Clin Pharmacol. 1986 May;21(5):552–552. doi: 10.1111/j.1365-2125.1986.tb02844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]